| Patent application number | Description | Published |
|---|
| 20100210651 | ISOXAZOLE-ISOXAZOLES AND ISOXAZOLE-ISOTHIAZOLES - The present invention is concerned with isoxazole-isoxazoles and isoxazole-isothiazoles of formula I, having affinity and selectivity for GABA A α5 receptor, their manufacture, pharmaceutical compositions containing them and their use as cognitive enhancers or for the therapeutic and/or prophylactic treatment of cognitive disorders like Alzheimer's disease. | 08-19-2010 |
| 20100216845 | ISOXAZOLES / O-PYRIDINES WITH ETHYL AND ETHENYL LINKER - The present invention is concerned with novel isoxazole-pyridines of formula I | 08-26-2010 |
| 20100280019 | ISOXAZOLES - The present invention is concerned with novel isoxazole derivatives of formula I | 11-04-2010 |
| 20100280020 | ISOXAZOLES - The present invention is concerned with novel isoxazole derivatives of formula I | 11-04-2010 |
| 20100286115 | PYRAZOLES - The present invention is concerned with isoxazole-pyrazoles of formula I, having affinity and selectivity for GABA A a5 receptor, their manufacture, pharmaceutical compositions containing them and their use as therapeutics. The active compounds of the present invention are useful as cognitive enhancer or for the therapeutic and/or prophylactic treatment of cognitive disorders like Alzheimer's disease. | 11-11-2010 |
| 20100286116 | THIAZOLES - The present invention is concerned with isoxazole-thiazole derivatives of formula I, having affinity and selectivity for GABA A α5 receptor, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful as cognitive enhancer or for the therapeutic and/or prophylactic treatment of cognitive disorders like Alzheimer's disease. | 11-11-2010 |
| 20100286117 | PYRIDINES - The present invention is concerned with novel isoxazoles of formula I | 11-11-2010 |
| 20100286132 | PYRIDINES - The present invention is concerned with isoxazole-pyridines of formula I, having affinity and selectivity for GABA A α5 receptor, their manufacture, pharmaceutical compositions containing them and their use as pharmaceuticals. The active compounds of the present invention are useful as cognitive enhancer or for the therapeutic and/or prophylactic treatment of cognitive disorders like Alzheimer's disease. | 11-11-2010 |
| 20100286159 | PYRIDAZINES - The present invention is concerned with isoxazole-pyridazines of formula I, having affinity and selectivity for GABA A α5 receptor, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful as cognitive enhancer or for the therapeutic and/or prophylactic treatment of cognitive disorders like Alzheimer's disease. | 11-11-2010 |
